本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

科兴生物

6.47
+0.0000
成交量:- -
成交额:- -
市值:6.42亿
市盈率:6.66
高:6.47
开:6.47
低:6.47
收:6.47
数据加载中...
2024/09/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/05

SEC问询函

Form CORRESP - Correspondence
2023/09/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/02

SEC问询函

Form CORRESP - Correspondence
2023/07/11

SEC问询函

Form CORRESP - Correspondence
2023/05/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/12/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]